Goldman Sachs’s Juno Therapeutics, Inc. JUNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,594,770
| Closed | -$72.9M | – | 4419 |
|
|
2017
Q4 | $72.9M | Buy |
1,594,770
+674,093
| +73% | +$30.8M | 0.02% | 863 |
|
|
2017
Q3 | $41.3M | Buy |
920,677
+53,296
| +6% | +$2.39M | 0.01% | 1177 |
|
|
2017
Q2 | $25.9M | Buy |
867,381
+7,521
| +0.9% | +$225K | 0.01% | 1412 |
|
|
2017
Q1 | $19.1M | Buy |
859,860
+711,209
| +478% | +$15.8M | 0.01% | 1530 |
|
|
2016
Q4 | $2.8M | Sell |
148,651
-165,514
| -53% | -$3.12M | ﹤0.01% | 2504 |
|
|
2016
Q3 | $9.43M | Sell |
314,165
-16,258
| -5% | -$488K | ﹤0.01% | 1882 |
|
|
2016
Q2 | $12.7M | Buy |
330,423
+224,545
| +212% | +$8.63M | ﹤0.01% | 1628 |
|
|
2016
Q1 | $4.03M | Sell |
105,878
-228,410
| -68% | -$8.7M | ﹤0.01% | 2172 |
|
|
2015
Q4 | $14.7M | Buy |
334,288
+193,502
| +137% | +$8.51M | ﹤0.01% | 1489 |
|
|
2015
Q3 | $5.73M | Buy |
140,786
+125,706
| +834% | +$5.12M | ﹤0.01% | 1941 |
|
|
2015
Q2 | $804K | Sell |
15,080
-1,981
| -12% | -$106K | ﹤0.01% | 3060 |
|
|
2015
Q1 | $1.04M | Buy |
+17,061
| New | +$1.04M | ﹤0.01% | 2888 |
|